Daniel Schneiderman - Insider Trading & Ownership

Entity
Individual
Location
760 Parkside Ave. Suite 304, Suite 207, Brooklyn, NY
All Insider Reports
All Insider Reports

Ownership of Daniel Schneiderman

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ENTO Entero Therapeutics, Inc. Chief Financial Officer Jan 3, 2022
KTTA, KTTAW Pasithea Therapeutics Corp. Chief Financial Officer Mar 1, 2024

Insider Transactions Reported by Daniel Schneiderman:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.